Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
RPID Transcript
Rapid Micro Biosystems, Inc. (RPID) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-15
Rapid Micro Biosystems, Inc. (RPID) Q3 2025 Earnings Call Transcript
Positive11-7
The earnings call revealed positive signs such as a guidance raise due to a large multi-system order, consistent global demand, and improved service margins. Despite a net loss, operating expenses decreased, and cash reserves are strong. The MilliporeSigma partnership and high ROI investments further bolster the outlook. However, management's lack of clarity on some order specifics and onshoring timelines tempers enthusiasm. Overall, the positive factors outweigh the negatives, suggesting a stock price increase in the near term.
Rapid Micro Biosystems, Inc. (RPID) Q2 2025 Earnings Call Transcript
Unknown8-12
The earnings call presents a mixed picture: positive trends in recurring and service revenues, improved gross margins, and operational efficiencies are offset by negative product margins and ongoing net losses. The Q&A reveals industry uncertainties, particularly in pharma decision-making and trade dynamics, which temper optimism. The reaffirmed revenue guidance and stable consumables growth are positive, but market uncertainties and management's vague responses suggest caution. With no strong catalysts or significant negative factors, the overall sentiment is neutral, suggesting limited stock price movement in the short term.
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q1 2025 Earnings Call Transcript
Positive5-10
The earnings call revealed strong financial performance with a 28% revenue increase and improved margins. Despite competitive pressures and uncertainties, management's optimistic guidance and strategic focus on AI and collaboration with MilliporeSigma are likely to support stock price growth. The absence of shareholder return plans is a minor negative, but overall, the financial and strategic outlook suggests a positive market reaction.
RPID Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
